|
AE31996 |
FMoc-4-sulfoMethyl-Phe(Tce)-OH |
1146758-11-3 |
C27H24Cl3NO7S |
612.9060 |
VIEW DETAILS > |
|
AE81106 |
FMOC-ASP-ODMB |
155866-25-4 |
C28H27NO8 |
505.5159 |
VIEW DETAILS > |
|
AF13898 |
Faralimomab |
167816-91-3 |
|
|
VIEW DETAILS > |
|
BO84174 |
Fmoc-alpha-methyl-4-methoxy-L-phenylalanine |
1292317-35-1 |
|
|
VIEW DETAILS > |
|
AG01703 |
Furo[3,4-f]-1,3-benzodioxole-5,7-dione (9CI) |
4074-11-7 |
C9H4O5 |
192.1251 |
VIEW DETAILS > |
|
BR90154 |
Fmoc-Hph(4-CF3-3,5-F2)-OH |
2642726-47-2 |
|
|
VIEW DETAILS > |
|
AF14372 |
Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [R-(R*,R*)]-, (E)-2-butenedioate (2 |
143687-27-8 |
|
|
VIEW DETAILS > |
|
AI40066 |
Fmoc-arg(me)2-oh (asymmetrical) hydrochloride |
1820570-64-6 |
C23H29ClN4O4 |
460.9538 |
VIEW DETAILS > |
|
AT31647 |
Furan-2-yl(5-methylnaphthalen-1-yl)methanol |
356552-77-7 |
C16H14O2 |
238.2812 |
VIEW DETAILS > |
|
AT31880 |
Furan-3-yl(naphthalen-1-yl)methanol |
1016925-55-5 |
C15H12O2 |
224.2546 |
VIEW DETAILS > |